Edwards Lifesciences has further to run
EW recently had a nice earnings beat and guidance raise. It is showing strong momentum and has broken out of a multi-year pattern. I bought a couple weeks ago, it may be vulnerable to some consolidation shortly but I think it will finish the year strongly. My target is $160 with a stop at $114.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.